SUPPRESSION OF MALIGNANT PHENOTYPE IN A HUMAN PROSTATE-CANCER CELL-LINE BY FRAGMENTS OF NORMAL CHROMOSOMAL REGION 17Q

被引:0
|
作者
MURAKAMI, YS
BROTHMAN, AR
LEACH, RJ
WHITE, RL
机构
[1] UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112
[3] UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112
[4] UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent evidence obtained by in situ hybridization indicates that chromosomal region 17q is often lost in prostate tumors, To substantiate the presence of tumor suppressor genes in this chromosomal region, normal human 17q tagged with a neomycin resistance gene was transferred into a human prostate cancer cell line, PPC-I, by microcell-mediated chromosome transfer, Two hybrid clones were obtained, both of which shelved decreased tumorigenicity in athymic nude mice and decreased efficiency of colony formation in soft agar with respect to PPC-1. When microcells were irradiated prior to transfer of chromosomal region 17q to determine which subchromosomal regions carry the potential tumor suppressor gene(s), 10 hybrid clones were obtained, including 6 fully malignant and 4 suppressed clones, Analysis of polymorphic loci on 17q in the series of hybrid clones suggested that a tumor suppressor gene associated with prostate cancer was located in a region no more than 28 cM long at 17q12-q22, which includes the BRCA1 gene involved in hereditary breast cancer.
引用
收藏
页码:3389 / 3394
页数:6
相关论文
共 50 条
  • [1] Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10
    Murakami, YS
    Albertsen, H
    Brothman, AR
    Leach, RJ
    White, RL
    CANCER RESEARCH, 1996, 56 (09) : 2157 - 2160
  • [2] LOSS OF HETEROZYGOSITY OF THE BRCA1 AND OTHER LOCI ON CHROMOSOME 17Q IN HUMAN PROSTATE-CANCER
    GAO, X
    ZACHAREK, A
    SALKOWSKI, A
    GRIGNON, DJ
    SAKR, W
    PORTER, AT
    HONN, KV
    CANCER RESEARCH, 1995, 55 (05) : 1002 - 1005
  • [3] ANDROGENS INHIBIT THE PROLIFERATION OF A VARIANT OF THE HUMAN PROSTATE-CANCER CELL-LINE LNCAP
    JOLYPHARABOZ, MO
    SOAVE, MC
    NICOLAS, B
    MEBARKI, F
    RENAUD, M
    FOURY, O
    MOREL, Y
    ANDRE, JG
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (01): : 67 - 76
  • [4] LOCALIZATION OF POTENTIAL TUMOR-SUPPRESSOR LOCI TO A LESS-THAN-2 MB REGION ON CHROMOSOME 17Q IN HUMAN PROSTATE-CANCER
    GAO, X
    ZACHAREK, A
    GRIGNON, DJ
    SAKR, W
    POWELL, IJ
    PORTER, AT
    HONN, KV
    ONCOGENE, 1995, 11 (07) : 1241 - 1247
  • [5] CALCIUM REGULATION OF ANDROGEN RECEPTOR EXPRESSION IN THE HUMAN PROSTATE-CANCER CELL-LINE LNCAP
    GONG, YW
    BLOK, LJ
    PERRY, JE
    LINDZEY, JK
    TINDALL, DJ
    ENDOCRINOLOGY, 1995, 136 (05) : 2172 - 2178
  • [6] LOSS OF THE CHROMOSOMAL REGION 10Q23-25 IN PROSTATE-CANCER
    GRAY, IC
    PHILLIPS, SMA
    LEE, SJ
    NEOPTOLEMOS, JP
    WEISSENBACH, J
    SPURR, NK
    CANCER RESEARCH, 1995, 55 (21) : 4800 - 4803
  • [7] IMMUNOLOGICAL CHARACTERIZATION AND ACTIVITY OF TRANSGLUTAMINASES IN HUMAN NORMAL AND MALIGNANT PROSTATE AND IN PROSTATE-CANCER CELL-LINES
    FRIEDRICHS, B
    RIEDMILLER, H
    GOEBEL, HW
    RAUSCH, U
    AUMULLER, G
    UROLOGICAL RESEARCH, 1995, 23 (05): : 301 - 310
  • [8] ANDROGEN MODULATION OF PROSTATE-CANCER CELL ANDROGEN RECEPTOR CONTENT IS CELL-LINE SPECIFIC
    LIN, AL
    SHAIN, SA
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1989, 63 (1-2) : 75 - 83
  • [9] EVIDENCE FOR A NOVEL MECHANISM OF ANDROGEN RESISTANCE IN THE HUMAN PROSTATE-CANCER CELL-LINE, PC-3
    TILLEY, WD
    BENTEL, JM
    ASPINALL, JO
    HALL, RE
    HORSFALL, DJ
    STEROIDS, 1995, 60 (01) : 180 - 186
  • [10] GROWTH OF AN ANDROGEN-SENSITIVE HUMAN PROSTATE-CANCER CELL-LINE, LNCAP, IN NUDE-MICE
    LIM, DJ
    LIU, XL
    SUTKOWSKI, DM
    BRAUN, EJ
    LEE, C
    KOZLOWSKI, JM
    PROSTATE, 1993, 22 (02): : 109 - 118